vs
Side-by-side financial comparison of Gossamer Bio, Inc. (GOSS) and MODIV INDUSTRIAL, INC. (MDV). Click either name above to swap in a different company.
Gossamer Bio, Inc. is the larger business by last-quarter revenue ($13.8M vs $11.1M, roughly 1.2× MODIV INDUSTRIAL, INC.). MODIV INDUSTRIAL, INC. runs the higher net margin — 11.0% vs -342.3%, a 353.3% gap on every dollar of revenue. On growth, Gossamer Bio, Inc. posted the faster year-over-year revenue change (47.1% vs -5.6%).
Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics for patients with serious immunology, inflammation and oncology conditions. It advances a pipeline of proprietary product candidates across multiple clinical phases, primarily serving healthcare markets in North America and other global regions.
MODIV INDUSTRIAL, INC. is a U.S.-based industrial real estate enterprise focused on acquiring, owning and operating high-quality industrial properties mainly located in key logistics and distribution hubs across North America. It serves tenants from sectors including e-commerce fulfillment, manufacturing and third-party logistics, addressing rising demand for modern supply chain infrastructure.
GOSS vs MDV — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.8M | $11.1M |
| Net Profit | $-47.2M | $1.2M |
| Gross Margin | — | — |
| Operating Margin | -333.6% | 45.8% |
| Net Margin | -342.3% | 11.0% |
| Revenue YoY | 47.1% | -5.6% |
| Net Profit YoY | -43.0% | -22.0% |
| EPS (diluted) | $-0.21 | $0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | $11.1M | ||
| Q3 25 | $13.3M | $11.7M | ||
| Q2 25 | — | $11.8M | ||
| Q1 25 | — | $11.8M | ||
| Q4 24 | — | $11.7M | ||
| Q3 24 | — | $11.7M | ||
| Q2 24 | $95.8M | $11.4M | ||
| Q1 24 | $0 | $12.0M |
| Q4 25 | $-47.2M | $1.2M | ||
| Q3 25 | $-48.2M | $1.0M | ||
| Q2 25 | — | $-2.0M | ||
| Q1 25 | — | $829.0K | ||
| Q4 24 | — | $1.6M | ||
| Q3 24 | — | $-587.0K | ||
| Q2 24 | $49.2M | $1.3M | ||
| Q1 24 | $-41.9M | $3.7M |
| Q4 25 | -333.6% | 45.8% | ||
| Q3 25 | -369.4% | 41.4% | ||
| Q2 25 | — | 9.8% | ||
| Q1 25 | — | 40.2% | ||
| Q4 24 | — | 45.4% | ||
| Q3 24 | — | 42.0% | ||
| Q2 24 | 54.3% | 44.6% | ||
| Q1 24 | — | 55.6% |
| Q4 25 | -342.3% | 11.0% | ||
| Q3 25 | -362.7% | 9.0% | ||
| Q2 25 | — | -17.1% | ||
| Q1 25 | — | 7.0% | ||
| Q4 24 | — | 13.3% | ||
| Q3 24 | — | -5.0% | ||
| Q2 24 | 51.4% | 11.6% | ||
| Q1 24 | — | 31.1% |
| Q4 25 | $-0.21 | $0.02 | ||
| Q3 25 | $-0.21 | $0.00 | ||
| Q2 25 | — | $-0.32 | ||
| Q1 25 | — | $-0.01 | ||
| Q4 24 | — | $0.07 | ||
| Q3 24 | — | $-0.18 | ||
| Q2 24 | $0.22 | $0.03 | ||
| Q1 24 | $-0.19 | $0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $136.9M | $14.4M |
| Total DebtLower is stronger | — | $261.5M |
| Stockholders' EquityBook value | $-122.8M | $162.7M |
| Total Assets | $172.2M | $476.5M |
| Debt / EquityLower = less leverage | — | 1.61× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $136.9M | $14.4M | ||
| Q3 25 | $180.2M | $8.3M | ||
| Q2 25 | — | $5.8M | ||
| Q1 25 | — | $6.2M | ||
| Q4 24 | — | $11.5M | ||
| Q3 24 | — | $6.8M | ||
| Q2 24 | $354.5M | $18.9M | ||
| Q1 24 | $244.4M | $18.4M |
| Q4 25 | — | $261.5M | ||
| Q3 25 | — | $279.7M | ||
| Q2 25 | — | $279.7M | ||
| Q1 25 | — | $279.7M | ||
| Q4 24 | — | $279.8M | ||
| Q3 24 | — | $279.7M | ||
| Q2 24 | — | $279.7M | ||
| Q1 24 | — | $279.6M |
| Q4 25 | $-122.8M | $162.7M | ||
| Q3 25 | $-82.3M | $164.8M | ||
| Q2 25 | — | $165.6M | ||
| Q1 25 | — | $171.1M | ||
| Q4 24 | — | $190.1M | ||
| Q3 24 | — | $186.3M | ||
| Q2 24 | $81.5M | $187.0M | ||
| Q1 24 | $26.7M | $188.0M |
| Q4 25 | $172.2M | $476.5M | ||
| Q3 25 | $208.8M | $499.6M | ||
| Q2 25 | — | $498.9M | ||
| Q1 25 | — | $506.8M | ||
| Q4 24 | — | $507.8M | ||
| Q3 24 | — | $507.4M | ||
| Q2 24 | $373.4M | $519.5M | ||
| Q1 24 | $259.4M | $522.5M |
| Q4 25 | — | 1.61× | ||
| Q3 25 | — | 1.70× | ||
| Q2 25 | — | 1.69× | ||
| Q1 25 | — | 1.63× | ||
| Q4 24 | — | 1.47× | ||
| Q3 24 | — | 1.50× | ||
| Q2 24 | — | 1.50× | ||
| Q1 24 | — | 1.49× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.3M | $15.0M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | 12.34× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.3M | $15.0M | ||
| Q3 25 | $-36.2M | $4.1M | ||
| Q2 25 | — | $3.9M | ||
| Q1 25 | — | $3.0M | ||
| Q4 24 | — | $18.2M | ||
| Q3 24 | — | $5.1M | ||
| Q2 24 | $116.3M | $4.7M | ||
| Q1 24 | $-52.3M | $3.0M |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 12.34× | ||
| Q3 25 | — | 3.95× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 3.68× | ||
| Q4 24 | — | 11.72× | ||
| Q3 24 | — | — | ||
| Q2 24 | 2.36× | 3.55× | ||
| Q1 24 | — | 0.80× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
